Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 19, 2025, XBiotech (XBIT) has a market cap of $89.634 million USD. According to our data, XBiotech is ranked No.7672 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 19, 2025 | $89.63 M |
-25.56%
|
| Dec 31, 2024 | $0.12 B |
-1.25%
|
| Dec 29, 2023 | $0.12 B |
13.96%
|
| Dec 30, 2022 | $0.11 B |
-68.46%
|
| Dec 31, 2021 | $0.34 B |
-17.46%
|
| Dec 31, 2020 | $0.41 B |
-16.15%
|
| Dec 31, 2019 | $0.49 B |
267.42%
|
| Dec 31, 2018 | $0.13 B |
28.93%
|
| Dec 29, 2017 | $0.10 B |
-61.07%
|
| Dec 30, 2016 | $0.27 B |
-6.90%
|
| Dec 31, 2015 | $0.29 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Amgen
AMGN
|
$149.09 B |
0.124 B
|
USA
|
 Regeneron Pharmaceuticals
REGN
|
$61.57 B |
1.023 B
|
USA
|
 Gilead Sciences
GILD
|
$130.32 B |
-0.001 M
|
USA
|
 Biogen
BIIB
|
$17.36 B |
-0.001 M
|
USA
|
 Vertex Pharmaceuticals
VRTX
|
$125.74 B |
-0.003 M
|
USA
|
 Moderna
MRNA
|
$9.56 B |
-0.000 M
|
USA
|
 BioMarin Pharmaceutical
BMRN
|
$11.35 B |
0.000 M
|
USA
|
 Incyte
INCY
|
$11.27 B |
0.000 M
|
USA
|
 Illumina
ILMN
|
$11.27 B |
-0.000 M
|
USA
|
 Alnylam Pharmaceuticals
ALNY
|
$30.36 B |
0.000 M
|
USA
|
 Sarepta Therapeutics
SRPT
|
$5.22 B |
0.000 M
|
USA
|
 bluebird bio
BLUE
|
$40.53 M |
0.000 M
|
USA
|
 CRISPR Therapeutics
CRSP
|
$3.26 B |
0.000 M
|
Switzerland
|
 Novavax
NVAX
|
$0.97 B |
0.000 M
|
USA
|
| Market Cap | = | XBIT Stock Price | * | XBIT Shares Outstanding |
| = | $2.94 | * | 30.49 M | |
| = | $89.63 M |